Skip to main content
Top

Journal of Cancer Research and Clinical Oncology

Issue 5/2001

Content (9 Articles)

REVIEW

Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology

B. van der Hiel, E. K. J. Pauwels, M. P. M. Stokkel

REVIEW

Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology

M. P. M. Stokkel, A. Draisma, E. K. J. Pauwels

ORIGINAL PAPER

Intestinal permeability in patients with chemotherapy-induced stomatitis

Bohuslav Melichar, Pavel Kohout, Miluše Brátová, Dagmar Solichová, Pavlína Králíčková, Zdenek Zadák

ORIGINAL PAPER

Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma

T. Olencki, D. Peereboom, L. Wood, G. T. Budd, A. Novick, J. Finke, D. McLain, P. Elson, R. M. Bukowski

ORIGINAL PAPER

Exploring the mechanisms of action of FB642 at the cellular level

Lisa A. Hammond, Karen Davidson, Richard Lawrence, James B. Camden, Daniel D. Von Hoff, Steve Weitman, Elzbieta Izbicka

RAPID COMMUNICATION

Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas

Martina Schiebe, Petra Ohneseit, Wolfgang Hoffmann, Richard Meyermann, Hans-Peter Rodemann, Michael Bamberg

ORIGINAL PAPER

Cancer mortality in the United States and Germany

Nikolaus Becker, Joshua E. Muscat, Ernst L. Wynder

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.